Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Cash & Current Investments: 2012-2025

Historic Cash & Current Investments for CorMedix (CRMD) over the last 12 years, with Sep 2025 value amounting to $56.6 million.

  • CorMedix's Cash & Current Investments rose 22.93% to $56.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $376.5 million, marking a year-over-year increase of 59.00%. This contributed to the annual value of $51.7 million for FY2024, which is N/A change from last year.
  • Per CorMedix's latest filing, its Cash & Current Investments stood at $56.6 million for Q3 2025, which was down 70.33% from $190.7 million recorded in Q2 2025.
  • In the past 5 years, CorMedix's Cash & Current Investments registered a high of $190.7 million during Q2 2025, and its lowest value of $45.6 million during Q2 2024.
  • For the 3-year period, CorMedix's Cash & Current Investments averaged around $72.1 million, with its median value being $56.1 million (2023).
  • Per our database at Business Quant, CorMedix's Cash & Current Investments plummeted by 46.84% in 2024 and then soared by 318.13% in 2025.
  • Over the past 5 years, CorMedix's Cash & Current Investments (Quarterly) stood at $65.5 million in 2021, then dropped by 10.19% to $58.8 million in 2022, then spiked by 46.76% to $86.6 million in 2023, then tumbled by 46.84% to $51.7 million in 2024, then increased by 22.93% to $56.6 million in 2025.
  • Its last three reported values are $56.6 million in Q3 2025, $190.7 million for Q2 2025, and $77.5 million during Q1 2025.